AccelerComm is an exciting semiconductor IP-core company that provides solutions to accelerate the next generations of wireless communications (3GPP rel 14, rel 15 and beyond). Their technology solves the bottleneck that would otherwise limit the speed of next generation wireless communication, namely the error correction decoding that is required to overcome the effects of noise, interference and poor signal strength.
Textmine is an E2E AI powered knowledge base for your business critical documents (things like invoices, payslips, tender documents, compliance reports and even contracts). We consolidate everything into a single operational layer to enable proactive decision making. We give Increased data transparency, whilst allowing document creation to be more scalable and uniform. We’ve helped organisations save money and time whilst reducing their risk profile and increasing compliance.
Opsydia is set to disrupt a number of industries by its ability to create practically invisible structures inside transparent materials. Permanent and inimitable serial numbers, images or cryptographic data can be laser-written without compromising the integrity of the material or modifying its surface. Material applications include diamond, glass and polymers
MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems.
Ceryx Medical is developing bioelectronics based on unique, patent protected, chip technology which is able to mimic nerve centres within the body called Central Pattern Generators (CPGs). These CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate and even walking. It is hoped that Ceryx’s artificial CPGs can restore normal performance where these processes have been affected by disease or injury.
Gripable develops digital therapy tools, combining them with mobile games, and motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering from impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of the hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.
NK:IO is a biotechnology company focused on advancing natural killer cell-mediated immunotherapy, particularly in the realm of cancer treatment. The company specializes in developing innovative cell therapies and small molecule therapeutics designed to enhance the effectiveness of cancer targeting for physicians. By leveraging cutting-edge research and technology, NK:IO aims to improve treatment outcomes for patients facing cancer.
Sano Genetics is a health technology company that focuses on personalized medicine and genetics. They aim to empower individuals to contribute their genetic and health data for research purposes, with the goal of advancing scientific understanding and personalized approaches to healthcare. Sano Genetics often operates within the context of genetic research studies and projects, allowing participants to share their genetic information to contribute to the broader field of medical research
SERG Technologies is re-defining the way we interact with technology by creating reliable and functional wearables that can be used for activity tracking, monitoring health and fitness, and gesture recognition for smart devices. Our unique sensors detect tiny, subconscious movements that indicate a wearer’s intent, we turn these into control signals for everything from TV’s to smart prosthetics, resulting in almost instant response times. We are also developing new tools to allow Parkinson's patients to track their symptoms, providing vital new information to their doctors, leading to long term improvements to the efficacy their treatment. SERG was founded to make the gesture control of technology accessible for everyone and easier to use than ever before.
BibliU provides colleges and universities with digital content management, automation, and analytics platform. BibliU’s solution puts digital textbooks, courseware, and monographs at the fingertips of all students. Working with thousands of publishers and OER providers to deliver millions of digital resources, BibliU combines academic freedom with innovative affordability and automation.
Semarion is a spin-out from the Cavendish Laboratory at the University of Cambridge, specializing in drug discovery and cell microcarrier technology. The company aims to enhance the process of drug screening by utilizing innovative materials and techniques from the microchip industry combined with cell biology. Its platform features ultra-miniaturized, magnetically steerable microcarriers designed to support small colonies of cells, which facilitates advanced assaying workflows and new experimental approaches. This technology is particularly focused on identifying GPCR-targeting oncology drugs, addressing significant gaps in medical needs and accelerating the pace of drug development.
Paragraf produces graphene electronic devices using contamination-free technology to deliver commercial-quality products. The company aims to significantly transform the electronics industry by developing high-purity graphene products that enhance technological performance. Paragraf is committed to driving material advancements in electronics through its innovative approach.
Barocal specializes in innovative cooling technology aimed at addressing low-carbon refrigeration needs. The company has developed a system that utilizes materials capable of significant thermal changes when pressure is applied or removed. This unique approach enhances energy efficiency while ensuring a zero greenhouse warming impact, particularly in the commercial food and drink refrigeration sector. By implementing Barocal's technology, clients can effectively reduce their indirect emissions of greenhouse gases, contributing to a more sustainable environment.
Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.
Founded to commercialise technology developed at Oxford University, Orthox aims to revolutionise the way cartilage injuries are treated. Trauma and erosion of the smooth, stiff cartilage in our joints leads to Osteoarthritis (OA) a debilitating disease, which affects over 300 million patients globally and costs the US economy alone over $128 billion each year. Current therapies to repair damaged cartilage focus either on tissue regeneration or on functional replacement; Orthox’s exceptionally strong, resilient, regenerative hydrogel technology, FibroFix™ achieves both these goals, offering a unique solution for the millions of patients suffering from damage to their joints. Initially targeting the knee, Orthox has developed a compelling set of data on lead product FibroFix™ Cartilage which has secured major awards from multiple funding bodies and will shortly enter clinical trials. FibroFix™ technology will then be rolled out to treat other joints and Orthox also has pipeline developments beyond orthopaedics in which strength and tissue regeneration are key. Pipeline expansion is valuable as growth in the annual global biomaterials market will exceed $250 billion by 2025. Orthopaedic biomaterials will form the largest proportion of this and natural biomaterials, like FibroFix™, will be the fastest growing market segment. Orthox: Reducing Pain, Increasing Mobility, Regenerating Strength™.
Sano Genetics is a health technology company that focuses on personalized medicine and genetics. They aim to empower individuals to contribute their genetic and health data for research purposes, with the goal of advancing scientific understanding and personalized approaches to healthcare. Sano Genetics often operates within the context of genetic research studies and projects, allowing participants to share their genetic information to contribute to the broader field of medical research
Paragraf produces graphene electronic devices using contamination-free technology to deliver commercial-quality products. The company aims to significantly transform the electronics industry by developing high-purity graphene products that enhance technological performance. Paragraf is committed to driving material advancements in electronics through its innovative approach.
Cambridge Touch Technologies, Ltd. develops next-generation UltraTouch technology for smart devices such as smartphones, tablets, automotive and industrial applications. Combining a proprietary AI engine running sophisticated signal processing algorithms with an advanced Piezoelectric Force Film, UltraTouch enables the world’s simplest all-in-one touch and force sensor architecture that delivers superior functionality at lower cost, and scales to all device sizes and shapes (including curved and foldable)
Diffblue is a developer of automated testing software that enhances Java development by automatically generating unit tests. The company is a spin-out of the AI research group at Oxford, its automated code-writing capability has far-reaching potential and will eventually transform how software is written. Initially, Diffblue’s technology was deployed to save developers time and ensure robustness in one of software development's most tedious and time-consuming areas: writing unit tests. Diffblue's product stands out from code suggestion tools in that it works completely autonomously, using reinforcement learning to write fully formed tests that are guaranteed to compile, run, and find bugs.
Pathfinder Medical is developing a novel electronic guidance system that will enable clinicians to connect blood vessels in a minimally invasive way. This platform technology has a variety of clinical applications such as bypassing peripheral blockages and in vascular access creation for dialysis patients, which represents a £1.6b yearly market.
Psyomics is engaged in the development of proteomic diagnostics aimed at improving the early diagnosis and treatment outcomes for individuals with neuropsychiatric disorders. The company offers a web-based assessment triage system that integrates digital profiling with advancements in biological research to enhance diagnostic accuracy. This approach assists primary care practitioners in effectively managing their patients' mental health needs by replicating a psychiatric assessment at the initial point of contact. By doing so, Psyomics facilitates improved recovery outcomes for patients suffering from mental health disorders.
Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.
Charco Neurotech is a medical technology company that develops non-invasive wearable devices.
Carbon Re is a climate technology company developing artificial intelligence to decarbonize energy-intensive industries. It intends to use AI technology to reduce carbon emissions by gigatonnes per year. Its emphasis is on energy-intensive industries like cement, steel, and glass, which account for more than 20% of global emissions. Deep learning is used by Carbon Re's Delta Zero platform for industrial decarbonization to enable rapid development and deployment of new low-carbon industrial processes, designs, and materials.
Cheesecake Energy specializes in the development of advanced thermal and compressed air energy systems that facilitate the storage of energy from intermittent renewable sources. By converting this stored energy into reliable power on demand, the company addresses the challenges associated with renewable energy variability. Cheesecake Energy's technology employs a combination of compressed air and thermal energy storage, utilizing industrial components that are readily available in the market. This approach not only enhances the durability of the storage systems but also allows clients to acquire these devices at a competitive price, making renewable energy more accessible and dependable.
PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. they are using the highest quality science to make the therapies their pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, they are applying the cutting edge of science to bring breakthroughs for the animals they love and care for.
Helio develops materials for a new generation of brighter, more colorful displays. Helio's materials can display richer, less filtered colors, resulting in a better overall visual experience while using significantly less power. Helio is on a mission to improve display performance and efficiency through the use of perovskite science. In order to speed up sound research and development, they collaborate with the scientific and business minds in their industry.
Nozzle.ai is an eCommerce and advertising optimization platform for Amazon. Nozzle.ai delivers direct-to-consumer level insights about customers on Amazon to beat the competition and grow businesses. Nozzle.ai aims to simplify the selling experience on Amazon.
Nyobolt is a developer of high-power battery technology used to serve automotive applications. It researches and develops battery technology that could have a higher power, recharge at a faster speed and store large amounts of energy that helps the automotive industry with solutions for high-power applications. The company was founded in 2020 and is based in Cambridge, United Kingdom.
Echion Technologies specializes in developing advanced anode materials for Li-ion batteries. Their XNO® material boasts faster charging times, longer lifespans, and improved safety compared to traditional options. Echion targets the heavy-duty electric vehicle market, aiming to improve efficiency and sustainability within the transportation sector.
Bonnet aims to reduce the headache associated with drivers having to register separately for individual public charging networks to charge their car. Instead, we provide a service for drivers and businesses that allows them to use any public charger with just one app.
Private Equity Round in 2021
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally. We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.
Fresh Check is a simple sticker that you put inside the packaging of food that changes colour when your food has actually gone off, not when the use-by date says so.
Oxford Endovascular is focused on developing an innovative medical device for the treatment of brain aneurysms. The company's technology employs a laser-cut metal alloy with shape-memory properties, which can be inserted into a patient's brain via a catheter. Once in place, the device expands into a tiny mesh tube, known as a flow diverter, that conforms to the natural shape of the blood vessel. This design effectively diverts blood flow away from the aneurysm, facilitating its healing and reducing the risk of rupture. By utilizing advanced origami engineering, Oxford Endovascular aims to enhance patient outcomes and improve survival rates for those affected by intracranial aneurysms.
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.
PredictImmune is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis). Based on world-leading research at Cambridge University, UK, they are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payors all recognise the value of such an approach to the management of Inflammatory Bowel Disease.
Mach42 is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source human cell type. The platforms can be used to enhance existing stem-cell forward programming methods, or bypass development pathways altogether, affecting a direct transdifferentiation between a mature cell type to another mature cell type. Mogrify is applying its proprietary and award-winning platforms to generate the functional cell types required to transform the lives of patients, by delivering a novel class of in vivo reprogramming therapies across ophthalmology, otology, metabolic and other areas of degenerative disease. Uniquely positioned to address a regenerative medicine market estimated to be worth $150 billion USD by 2028, Mogrify is commercializing its technology via a combination of in vivo reprogramming therapy development, co-development partnerships, as well as the exploitation of the platform in other therapeutic and non-therapeutic applications.
iKVA is an AI knowledge management software company.
Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existing bio-design limits imposed by conventional peptide synthesis, with one universal process.
Abselion is the biological sensor for rapid and cost-effective detection of biological substances like proteins, DNA, or small molecules.
Oxford Endovascular is focused on developing an innovative medical device for the treatment of brain aneurysms. The company's technology employs a laser-cut metal alloy with shape-memory properties, which can be inserted into a patient's brain via a catheter. Once in place, the device expands into a tiny mesh tube, known as a flow diverter, that conforms to the natural shape of the blood vessel. This design effectively diverts blood flow away from the aneurysm, facilitating its healing and reducing the risk of rupture. By utilizing advanced origami engineering, Oxford Endovascular aims to enhance patient outcomes and improve survival rates for those affected by intracranial aneurysms.
Carbometrics is a specialist chemistry company .Our core competency is the design, synthesis and derivatisation of highly selective and robust carbohydrate-binding molecules. Our technology is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis’ group at the University of Bristol. Carbometrics’ goal is to exploit our GBM technology to realise a highly robust and accurate glucose sensing platform that can be used to create a market-leading Continuous Glucose Monitoring (CGM) solution. The company was set up after the founders sold their first company Ziylo to Novo Nordisk, which is using the same platform to develop smart insulins.
Gripable develops digital therapy tools, combining them with mobile games, and motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering from impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of the hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.
Riverlane creates and engineers instruments. With the help of the manufacturers of quantum computers, they put them into practice. New hardware and software tools are needed to regulate intrinsically unstable qubits and completely fix system defects ten billion times or more per second in order to unlock the entire range of quantum computing applications.
PhoreMost Limited is a drug discovery company based in Cambridge, United Kingdom, focused on identifying new druggable targets for cancer and other unmet diseases. Since its incorporation in 2014, the company has developed Site-Seeker, a platform that uncovers cryptic druggable sites within the human genome and connects them to therapeutic functions in live-cell contexts. This innovative approach allows PhoreMost to design small molecule drugs based on functionally validated protein fragments. By collaborating with a global network of academic and industrial partners, the company aims to bring novel targeted therapies to market more efficiently, ultimately benefiting patients through cost savings and the development of first-in-class drug discovery programs for potential licensing to pharmaceutical companies.
Entia is a medical technology company that specializes in improving access to blood tests. Its featured products include Aptus, designed for haemoglobin and haematocrit and Affinity, designed for people with cancer to monitor their blood counts at home. The company is a multidisciplinary team spanning design, engineering, quality assurance, business development, and innovation.
CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation of advanced therapies. We are a spinout company from the University of Bristol. Our novel cell membrane augmentation technology enables us to add new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer, heart disease, osteoarthritis and diabetic wound healing. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health.
Textmine is an E2E AI powered knowledge base for your business critical documents (things like invoices, payslips, tender documents, compliance reports and even contracts). We consolidate everything into a single operational layer to enable proactive decision making. We give Increased data transparency, whilst allowing document creation to be more scalable and uniform. We’ve helped organisations save money and time whilst reducing their risk profile and increasing compliance.
Cambridge GaN Devices focuses on the development of gallium nitride power devices that enhance energy efficiency in electronic applications. The company offers a range of GaN-based semiconductor products designed to improve power conversion and reduce energy loss in various systems. These devices are utilized in sectors such as renewable energy, electric vehicles, and consumer electronics, contributing to the advancement of greener technologies. Cambridge GaN Devices collaborates with industry partners to drive innovation and facilitate the adoption of its technology in the power semiconductor market.
Mirriad’s award-winning solution unleashes new revenue for content producers and distributors by creating new advertising inventory in content. Our patented, AI and computer vision technology dynamically inserts products and innovative signage formats after content is produced. Mirriad’s market-first solution seamlessly integrates with existing subscription and advertising models, and dramatically improves the viewer experience by limiting commercial interruptions. Mirriad currently operates in the US, Europe and China.
Phasecraft is a group of world-class quantum scientists and engineers who are tackling grand challenges by expediting the practical application of quantum computing. The company envisions a world in which breakthrough scientific discoveries are commonplace, allowing entrepreneurs to address the world's most pressing concerns more quickly.
NoBACZ is pioneering a novel, new precision bandaging platform for the veterinary and human market. The company specializes in rapid set liquid barriers.
Nozzle.ai is an eCommerce and advertising optimization platform for Amazon. Nozzle.ai delivers direct-to-consumer level insights about customers on Amazon to beat the competition and grow businesses. Nozzle.ai aims to simplify the selling experience on Amazon.
Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, Sapientia, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients. It was founded in 2013 and headquartered in Cambridge, Cambridgeshire.
Psyomics is engaged in the development of proteomic diagnostics aimed at improving the early diagnosis and treatment outcomes for individuals with neuropsychiatric disorders. The company offers a web-based assessment triage system that integrates digital profiling with advancements in biological research to enhance diagnostic accuracy. This approach assists primary care practitioners in effectively managing their patients' mental health needs by replicating a psychiatric assessment at the initial point of contact. By doing so, Psyomics facilitates improved recovery outcomes for patients suffering from mental health disorders.
1715 Labs Ltd specializes in data labeling services powered by artificial intelligence. Founded in 2018 and located in Oxford, United Kingdom, the company offers a range of solutions in computer vision and language processing. Its computer vision capabilities include image categorization and various forms of segmentation, while its language processing services encompass text classification, relationship identification, and sentiment recognition, among others. By combining human expertise with advanced statistical tools, 1715 Labs aims to provide organizations with rapid and cost-effective data training, labeling, and analysis, ultimately assisting businesses in effectively utilizing their data. Additionally, 1715 Labs is focused on commercializing Zooniverse technology to expand its offerings in the data labeling market.
MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems.
GeoSpock enables data fusion for the connected world with GeoSpock DB – the space-time analytics database. GeoSpock DB is a unique, cloud-native database optimised for querying for real-world use cases, able to fuse multiple sources of Internet of Things (IoT) data together to unlock its full value, whilst simultaneously reducing complexity and cost. GeoSpock DB enables efficient storage, data fusion, and rapid programmatic access to data, and allows you to run ANSI SQL queries and connect to standard analytics tools via flexible JDBC/ODBC connectors. Users are able to perform deep analysis and share insights using familiar toolsets, with plug and play support for common BI tools (such as Tableau™, Amazon QuickSight™, and Microsoft Power BI™), and Data Science and Machine Learning environments (including Python Notebooks and Apache Spark). The database can also be integrated with proprietary applications, web services, and internal tools – with compatibility for open-source and customisable visualisation libraries such as Kepler and Cesium.js.
Nyobolt is a developer of high-power battery technology used to serve automotive applications. It researches and develops battery technology that could have a higher power, recharge at a faster speed and store large amounts of energy that helps the automotive industry with solutions for high-power applications. The company was founded in 2020 and is based in Cambridge, United Kingdom.
Ceryx Medical is developing bioelectronics based on unique, patent protected, chip technology which is able to mimic nerve centres within the body called Central Pattern Generators (CPGs). These CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate and even walking. It is hoped that Ceryx’s artificial CPGs can restore normal performance where these processes have been affected by disease or injury.
Nu Quantum is building the quantum networking infrastructure essential to scaling quantum computers, by interconnecting quantum computing cores into large distributed clusters. We are creating full hardware solutions to create entangled qubit networks, including a unique high-speed computer network interface, photonic switching fabric, and control systems to accelerate the roadmap towards multi-core quantum supercomputers and quantum data centres. Partnering with leading QC companies, governments and research groups, we seek to bring this technology to market.
GaitQ Limited, founded in 2019 and based in Oxfordshire, United Kingdom, specializes in developing a medical device aimed at assisting individuals with Parkinson's disease in overcoming freezing of gait. The company's product, known as the GaitThaw device, is small and portable, designed to utilize clinically proven sensory cues. These cues facilitate the re-establishment of the connection between the brain and the body, enabling patients to walk more smoothly and confidently.
Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.
Symetrica Ltd. engages in the development and commercialization of radiation detection and identification systems for security, medical diagnostics, geophysical, and space research and development applications. The company was incorporated in 2002 and is based in Southampton, the United Kingdom.
Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.
Ceryx Medical is developing bioelectronics based on unique, patent protected, chip technology which is able to mimic nerve centres within the body called Central Pattern Generators (CPGs). These CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate and even walking. It is hoped that Ceryx’s artificial CPGs can restore normal performance where these processes have been affected by disease or injury.
Mind Foundry is an Oxford University Company. Operating at the intersection of innovation and usability, Mind Foundry empowers organisations through the use of Responsible AI built to tackle high-stakes, real-world problems at both individual and population scale. Mind Foundry’s AI Platform and technologies have been used to solve some of the most challenging applications of Machine Learning, from insurance fraud detection to complex signal processing, helping customers in insurance, infrastructure, and defence and security tackle the issues that matter most to them whilst promoting the responsible and transparent usage of AI. Founded by pioneers in the field of AI and Machine Learning, Oxford Professors Stephen Roberts and Michael Osborne, the mission of Mind Foundry is to create a future where humans and AI work together to solve the world’s most important problems.
Symetrica Ltd. engages in the development and commercialization of radiation detection and identification systems for security, medical diagnostics, geophysical, and space research and development applications. The company was incorporated in 2002 and is based in Southampton, the United Kingdom.
Qkine manufactures high-purity, animal-free growth factors, cytokines and other complex proteins. Based on the Cambridge Science Park, UK, we combine proprietary protein production processes developed at the University of Cambridge with protein engineering techniques to develop unique products that tackle fundamental biological and scale-up challenges for the fast-growing stem cell, organoid, regenerative medicine and cultivated meat sectors. Qkine has an active R&D pipeline, with a continually expanding product range. Unique products available from Qkine include tag-free thermostable FGF-2 (FGF2-G3), the first animal-free TGF beta 1 for chemically defined stem cell media, and animal-free HGF (NK1). Qkine is an ISO 9001: 2015 certified company.
Flusso is a semiconductor company that develops and manufactures sensor solutions for various industries. It provides and offers mass flow and air velocity sensors for proprietary technology uses. Flusso was founded in 2016 and is based in Cambridge, UK.
Oxford Flow Ltd. is a company that designs, manufactures, and supplies pressure control equipment, including gas regulators, water pressure reducing valves (PRVs), silencers, and pilots. Established in 2015 and based in Oxford, United Kingdom, the company serves a variety of industries such as water, gas, marine, oil and gas, process, power, and building services. Oxford Flow's products are engineered to simplify systems and enhance reliability while meeting rigorous standards for water quality and leakage control. The company focuses on delivering practical solutions that improve operational efficiency and reduce environmental impact, backed by extensive testing and customer feedback. By combining academic expertise with industry knowledge, Oxford Flow aims to provide innovative and efficient pressure control solutions that help customers save costs without compromising performance.
Quantum Motion Technologies is building a universal quantum computer in Silicon, using CMOS compatible processes.
Their sensors are based on film bulk acoustic resonator (FBAR) technology. The devices, fabricated on a silicon wafer, comprise a thin film of piezoelectric material that is made to resonate. Attachment of mass to the surface changes the resonant frequency and provides an extremely accurate measurement of the amount of mass on the sensing area.Their sensors are suited to applications where you need to detect small masses in a device with an extremely small form factor. Functionalising the surface of their devices means that they can selectively detect specific targets.
PervasID is developing a high reliability, wide area passive RFID system with the potential to provide location capability based on the EPC Class1 Gen2 standard. Spun out from research activity in the Engineering Department at the University of Cambridge, the technology is now successfully deployed in several field trials.
Xampla is a cleantech company that creates plant protein material for commercial use. Its materials include microcapsules, beads, films, threads, and other structures made from plant protein with biodegradable, biocompatible, and no synthetic ingredients used for food, cosmetics, household products, animal feed, packaging, and medical applications.
PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery of vital new medicines.
Ilika accelerates the development of new materials for energy and electronics applications through the use of its patented, high throughput techniques. Ilika’s technology enables functional materials to be made, characterised and tested up to 100 times faster than traditional techniques. Ilika has commercial partnerships with international blue-chip companies.
Audiotelligence leads the world in blind audio signal separation from multi-microphone captured audio. Our AudioTelligence nD technologies greatly out-perform existing 'state-of-the art' commercially available technologies such as beam forming, spectral masking, deep neural nets, non-negative matrix factorisation and ICA.
Echion Technologies specializes in developing advanced anode materials for Li-ion batteries. Their XNO® material boasts faster charging times, longer lifespans, and improved safety compared to traditional options. Echion targets the heavy-duty electric vehicle market, aiming to improve efficiency and sustainability within the transportation sector.
Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.
DIOSyn Vax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines) is new technology that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally. We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.
RoboK is a computer vision startup with a mission to make all industrial workplaces safe and high-performing with AI. The company develops innovative, privacy-preserving, and cost-effective technology to maximise the value of industrial CCTV cameras. RoboK is already working with some of the largest critical infrastructure operators, turning their on-site visual data into high-value actionable insights.
Paragraf produces graphene electronic devices using contamination-free technology to deliver commercial-quality products. The company aims to significantly transform the electronics industry by developing high-purity graphene products that enhance technological performance. Paragraf is committed to driving material advancements in electronics through its innovative approach.
Entia is a medical technology company that specializes in improving access to blood tests. Its featured products include Aptus, designed for haemoglobin and haematocrit and Affinity, designed for people with cancer to monitor their blood counts at home. The company is a multidisciplinary team spanning design, engineering, quality assurance, business development, and innovation.
CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation of advanced therapies. We are a spinout company from the University of Bristol. Our novel cell membrane augmentation technology enables us to add new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer, heart disease, osteoarthritis and diabetic wound healing. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health.
LettUs Grow is a team of growers, engineers, plant scientists, software developers and business experts, who all care deeply about food and the environment. Together we design and build aeroponic technology and farm management software for greenhouse and vertical farms. We believe careful innovation in farming can make the world a better place. Our technology reduces the environmental impact of agriculture and makes farmers’ lives easier. We are dedicated to making sustainable farming a sustainable business.
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.
Nozzle.ai is an eCommerce and advertising optimization platform for Amazon. Nozzle.ai delivers direct-to-consumer level insights about customers on Amazon to beat the competition and grow businesses. Nozzle.ai aims to simplify the selling experience on Amazon.
Inflowmatix is a spin-out company from the InfraSense Labs at the Department of Civil and Environmental Engineering of Imperial College London. Inflowmatix builds upon the unique cross-disciplinary expertise from sensing to advanced modelling and optimization and the active research collaborations with water utilities and IT system integrators. Inflowmatix creates innovative and customer tailored solutions for the steady-state, resilient and energy efficient operation of water supply networks by continuously monitoring and analyzing the fluid dynamics in complex networks. This allows operators to continuously gain unique insight and proactively optimize the dynamic network performance in order to extend the service life of infrastructure assets. Our expertise in modelling the steady and unsteady-state hydraulics of water distribution networks, combined with knowledge and experience in the design and implementation of embedded electronic systems, yield compelling returns on investment for our customers. Many cities in the world face the problem of ageing infrastructure, increasing population demand and climate change. This combined with increasing regulatory and financial pressure means water utilities are actively seeking novel, integrated and optimized operational strategies for managing leakage, demand and energy efficiency in order to deliver high-quality of service to customers within cost constraints. Water companies and operators are facing unparalleled challenges to meet increasing demand with limited water and financial resources. By successfully applying the technologies and analytics developed by Inflowmatix to water supply networks, we significantly improve the management of leakage, demand, energy and operational incidents, thus providing multiple operational benefits for network operators.
Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source human cell type. The platforms can be used to enhance existing stem-cell forward programming methods, or bypass development pathways altogether, affecting a direct transdifferentiation between a mature cell type to another mature cell type. Mogrify is applying its proprietary and award-winning platforms to generate the functional cell types required to transform the lives of patients, by delivering a novel class of in vivo reprogramming therapies across ophthalmology, otology, metabolic and other areas of degenerative disease. Uniquely positioned to address a regenerative medicine market estimated to be worth $150 billion USD by 2028, Mogrify is commercializing its technology via a combination of in vivo reprogramming therapy development, co-development partnerships, as well as the exploitation of the platform in other therapeutic and non-therapeutic applications.
Covatic Ltd, established in 2016 and headquartered in Birmingham, United Kingdom, specializes in broadcast personalization software. The company's innovative platform employs mobile-based algorithms to enhance user experience by delivering personalized content without compromising personal data. By identifying optimal engagement moments and methods for individuals, Covatic enables clients to effectively connect with their target audiences. This approach allows for the collection and personalization of insights, ultimately improving the way applications serve their users. With an emphasis on problem-solving, Covatic continues to develop solutions that enhance app functionality and user interaction.
Echopoint Medical Ltd is developing a family of optical-fibre based sensors which integrate into medical innovative devices: bringing unparalleled sensing modalities to minimally-invasive procedures.Echopoint Medical Ltd (EML) is a medical device company focused on transforming precision diagnosis and treatment of cardiovascular disease. A spin-out from the University College London, we are translating breakthroughs in fibre optic sensor technology to address key unmet needs of patients, clinicians, and healthcare providers.
YASA was founded on the principle that small, light electric motors would play a growing role in meeting both the strict emissions targets being set globally in a wide range of industries and the requirement for greater efficiency through electrification. The Company was incorporated in 2009 based on a unique patented motor technology invented by the Company’s founder and CTO Dr Tim Woolmer whilst studying for his DPhil at Oxford University. The unique YASA motor technology is ideal for a range of mobile applications such as hydraulics replacement, power generation, traction and propulsion and hybridisation. YASA Motors manufactures a range of standard electric motors and generators based on our unique motor topology at our factory and Company Headquarters in Abingdon, Oxfordshire. The YASA-750, YASA-250 and YASA-400 products have been designed to be integrated into customers’ products in a range of markets and industries with minimal application engineering. In addition to our standard products, YASA has a design and development team dedicated to making bespoke motors for customers for medium-high volume applications.
Undo is the time travel debugging company for Linux. We equip developers with the technology to understand complex code and fix bugs faster. Developers spend far too much time figuring out what code actually does – either to find and fix bugs or to understand other people’s code. With time travel debugging, developers can see exactly what the software did, and create better software faster. By integrating Undo’s LiveRecorder into their CI workflow, C/C++, Go, and Java software teams can easily and quickly diagnose the root causes of new regressions, legacy bugs, and flaky tests – before they hit customers. Thousands of developers across leading technology firms including SAP, Juniper Networks, and Siemens use LiveRecorder to improve developer productivity, developer velocity, and software quality.
MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems.
Mirriad’s award-winning solution unleashes new revenue for content producers and distributors by creating new advertising inventory in content. Our patented, AI and computer vision technology dynamically inserts products and innovative signage formats after content is produced. Mirriad’s market-first solution seamlessly integrates with existing subscription and advertising models, and dramatically improves the viewer experience by limiting commercial interruptions. Mirriad currently operates in the US, Europe and China.